» Articles » PMID: 3422592

Flavone Acetic Acid (NSC 347512)-induced DNA Damage in Glasgow Osteogenic Sarcoma in Vivo

Overview
Journal Cancer Res
Specialty Oncology
Date 1988 Mar 1
PMID 3422592
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Flavone acetic acid (FAA) is a new antitumor agent with broad activity against transplantable solid tumors of mice but with only scant or no activity against leukemias and lymphomas. The technique of alkaline elution was used to study DNA lesions in s.c. implanted Glasgow osteogenic sarcoma in C57BL/6 x DBA/2 F1 mice treated i.v. with FAA. At efficacious dosages (235 and 200 mg/kg), FAA produced extensive single strand breakage. Formation of single strand breaks was dependent on time of assay after exposure to FAA with only minimal damage occurring prior to 5 h posttreatment. Apparently Glasgow osteogenic sarcoma had no capacity to repair single strand breaks for at least 45 h after drug administration. Thus, FAA differs in its mechanism from other scission agents (e.g., VP-16). Neither interstrand cross-links nor DNA-protein cross-links were detected. DNA single strand breaks did not occur in the bone marrow cells or in the unresponsive P388 leukemia cells at dosages causing extensive DNA damage in solid tumor cells.

Citing Articles

Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.

Pham M, Rhinn H, Auzeil N, Regazzetti A, Harami D, Scherman D Drug Metab Lett. 2011; 5(2):73-84.

PMID: 21457135 PMC: 3743746. DOI: 10.2174/187231211795305221.


Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes.

Hirano T, Abe K, Gotoh M, Oka K Br J Cancer. 1995; 72(6):1380-8.

PMID: 8519648 PMC: 2034105. DOI: 10.1038/bjc.1995.518.


Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization.

De Forni M, Chabot G, Armand J, Gouyette A, Recondo G Cancer Chemother Pharmacol. 1995; 35(3):219-24.

PMID: 7805180 DOI: 10.1007/BF00686551.


Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.

Kerr D, Maughan T, NEWLANDS E, Rustin G, Bleehen N, Lewis C Br J Cancer. 1989; 60(1):104-6.

PMID: 2803908 PMC: 2247346. DOI: 10.1038/bjc.1989.230.


Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro.

Chabot G, Bissery M, Gouyette A Cancer Chemother Pharmacol. 1989; 24(5):273-6.

PMID: 2758556 DOI: 10.1007/BF00304757.